Carl Zeiss Meditec AG (ETR:AFX)

Market Cap	2.35B -53.1%
Revenue (ttm)	2.20B +5.9%
Net Income	120.61M -23.2%
EPS	1.40 -21.2%
Shares Out	87.54M
PE Ratio	19.21
Forward PE	15.30
Dividend	0.55 (2.04%)
Ex-Dividend Date	Mar 27, 2026

Volume	383,813
Average Volume	409,852
Open	27.10
Previous Close	27.00
Day's Range	26.60 - 27.46
52-Week Range	25.20 - 71.65
Beta	1.44
RSI	34.24
Earnings Date	Feb 12, 2026

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and p...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1846
• Employees: 5,784
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: AFX

Financial Performance

In fiscal year 2025, Carl Zeiss Meditec AG's revenue was 2.23 billion, an increase of 7.82% compared to the previous year's 2.07 billion. Earnings were 141.21 million, a decrease of -20.99%.